These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6117655)

  • 1. Cardiovascular effects of a 4'-methylthio analog of propranolol.
    Russel MP; Privitera PJ; Walle T; Peet NP; Halushka PV; Gaffney TE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):685-90. PubMed ID: 6117655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 3. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta-adrenergic blockade on the adaptation of the heart to increased arterial blood pressure].
    Miazgowski T
    Ann Acad Med Stetin; 1987; 33():21-38. PubMed ID: 2967653
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenoceptor blocking agents and their effects on heart and blood vessels.
    Clark BJ
    Arq Bras Cardiol; 1984 Apr; 42(4):237-42. PubMed ID: 6150700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of blockade of adrenergic beta receptors on the development of disorders of cardio- and hemodynamics in shock of immunologic origin].
    Sagach VF; Buriakov IE
    Patol Fiziol Eksp Ter; 1986; (6):32-4. PubMed ID: 2881243
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the coronary flow distribution during alpha adrenergic activation of the coronary vessels].
    Cartes F; Donoso R; Carrasco H; Cabezas P; Domenech RJ
    Rev Med Chil; 1983 Jan; 111(1):3-12. PubMed ID: 6316452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a new propranolol analogue on the rabbit myocardium in vitro.
    Olakowska E; Olakowski M
    Pol J Pharmacol; 2004; 56(1):105-11. PubMed ID: 15047984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT; Houdi AA
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ouabain and propranolol on the mechanical function and metabolism of the ischemic myocardium].
    da Luz PL; Forrester JS; Wyatt HL
    Arq Bras Cardiol; 1983 Mar; 40(3):155-61. PubMed ID: 6651553
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effect of a senso (toad venom) - containing drug in anesthetized dogs (2): Influence of propranolol.
    Ojiri Y; Chibana T; Noguchi K; Sakanashi M
    Am J Chin Med; 1992; 20(2):147-55. PubMed ID: 1519555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
    Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
    Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
    Kimura Y; Okuda H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol and midazolam therapy on hemodynamic parameters in rabbits.
    Wiktorowska-Owczarek A; Owczarek J; Obolewska A; Orszulak-Michalak D
    Med Sci Monit; 2000; 6(5):896-900. PubMed ID: 11208429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.